Initial studies on the cellular pharmacology of 2',3'-dideoxyinosine, an inhibitor of HIV infectivity. 1987

G Ahluwalia, and D A Cooney, and H Mitsuya, and A Fridland, and K P Flora, and Z Hao, and M Dalal, and S Broder, and D G Johns
Division of Cancer Treatment, National Cancer Institute, Bethesda, MD 20892.

UI MeSH Term Description Entries
D007288 Inosine A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)
D009711 Nucleotides The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleotide
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003838 Deoxyadenine Nucleotides Adenine nucleotides which contain deoxyribose as the sugar moiety. Deoxyadenosine Phosphates,Nucleotides, Deoxyadenine,Phosphates, Deoxyadenosine
D003854 Deoxyribonucleotides A purine or pyrimidine base bonded to a DEOXYRIBOSE containing a bond to a phosphate group. Deoxyribonucleotide
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D000409 Alanine A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM. Abufène,Alanine, L-Isomer,L-Alanine,Alanine, L Isomer,L Alanine,L-Isomer Alanine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

G Ahluwalia, and D A Cooney, and H Mitsuya, and A Fridland, and K P Flora, and Z Hao, and M Dalal, and S Broder, and D G Johns
July 1986, Biochemical pharmacology,
G Ahluwalia, and D A Cooney, and H Mitsuya, and A Fridland, and K P Flora, and Z Hao, and M Dalal, and S Broder, and D G Johns
December 1988, Biochemical pharmacology,
G Ahluwalia, and D A Cooney, and H Mitsuya, and A Fridland, and K P Flora, and Z Hao, and M Dalal, and S Broder, and D G Johns
September 1990, AIDS research and human retroviruses,
G Ahluwalia, and D A Cooney, and H Mitsuya, and A Fridland, and K P Flora, and Z Hao, and M Dalal, and S Broder, and D G Johns
March 1995, Medicina clinica,
G Ahluwalia, and D A Cooney, and H Mitsuya, and A Fridland, and K P Flora, and Z Hao, and M Dalal, and S Broder, and D G Johns
January 1992, The Journal of infectious diseases,
G Ahluwalia, and D A Cooney, and H Mitsuya, and A Fridland, and K P Flora, and Z Hao, and M Dalal, and S Broder, and D G Johns
May 1989, Biochemical pharmacology,
G Ahluwalia, and D A Cooney, and H Mitsuya, and A Fridland, and K P Flora, and Z Hao, and M Dalal, and S Broder, and D G Johns
September 1997, American journal of clinical pathology,
G Ahluwalia, and D A Cooney, and H Mitsuya, and A Fridland, and K P Flora, and Z Hao, and M Dalal, and S Broder, and D G Johns
October 1989, Biochemical and biophysical research communications,
G Ahluwalia, and D A Cooney, and H Mitsuya, and A Fridland, and K P Flora, and Z Hao, and M Dalal, and S Broder, and D G Johns
October 2004, Journal of peptide science : an official publication of the European Peptide Society,
G Ahluwalia, and D A Cooney, and H Mitsuya, and A Fridland, and K P Flora, and Z Hao, and M Dalal, and S Broder, and D G Johns
March 1991, Lancet (London, England),
Copied contents to your clipboard!